CLINICAL_TRIALS
withdrawal
· 2020-09-07
Clinical Trial Update: Nebulized Magnesium Sulfate in Pediatric Asthma [Phase 3]
Summary
A Phase 3 trial evaluating nebulized magnesium sulfate for pediatric asthma was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Asthma | Phase 3 | Status: WITHDRAWN